Orlistat is used for: Obesity.
Recorded in the NepalDoc medicine catalog for Orlistat.
ORLISTAT is indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. ORLISTAT is also indicated to reduce the risk for weight regain after prior weight loss.
From the U.S. FDA-approved label for Orlistat. Full label: DailyMed.
ORLISTAT is indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. ORLISTAT is also indicated to reduce the risk for weight regain after prior weight loss. ORLISTAT is indicated for obese patients with an initial body mass index (BMI) ≥30 kg/m 2 or ≥27 kg/m 2 in the presence of other risk factors (e.g., hypertension, diabetes, dyslipidemia). Table 1 illustrates body mass index (BMI) according to a variety of weights and heights. The BMI is calculated by dividing weight in kilograms by height in meters squared. For example, a person who weighs 180 lbs and is 5 ' 5 " would have a BMI of 30.
From the U.S. FDA-approved label for Orlistat. Full label: DailyMed.
One 120-mg capsule three times a day with each main meal containing fat (during or up to 1 hour after the meal). Advise patients to take a nutritionally balanced, reduced-calorie diet that contains approximately 30% of calories from fat. Distribute the daily intake of fat, carbohydrate, and protein over three main meals.
Directions from the U.S. FDA-approved label for Orlistat — your doctor or pharmacist may advise differently.
ORLISTAT is contraindicated in: Pregnancy Patients with chronic malabsorption syndrome Patients with cholestasis Patients with known hypersensitivity to ORLISTAT or to any component of this product Pregnancy Chronic malabsorption syndrome Cholestasis Known hypersensitivity to ORLISTAT or to any component of this product
Excerpt from the U.S. FDA-approved label for Orlistat. Talk to a pharmacist or doctor before use.
ORLISTAT has drug interactions and can decrease vitamin absorption. Take a multivitamin supplement that contains fat-soluble vitamins to ensure adequate nutrition. Rare cases of severe liver injury with hepatocellular necrosis or acute hepatic failure have been reported. Patients may develop oxalate nephrolithiasis and oxalate nephropathy following treatment with ORLISTAT. Monitor renal function in patients at risk for renal insufficiency. Discontinue ORLISTAT if oxalate nephropathy develops. Substantial weight loss can increase the risk of cholelithiasis.
Warnings and precautions excerpt from the U.S. FDA-approved label for Orlistat — not a complete list. Talk to a pharmacist or doctor before use.
Most common treatment emergent adverse reactions (≥5% and at least twice that of placebo) include oily spotting, flatus with discharge, fecal urgency, fatty/oily stool, oily evacuation, increased defecation and fecal incontinence. To report SUSPECTED ADVERSE REACTIONS, contact the Safety Call Center at 1-877-778-8969 or FDA at 1‑800‑FDA‑1088 (1-800-332-1088) or www.fda.gov/medwatch.
Excerpt from the U.S. FDA-approved label for Orlistat — not a complete list. Talk to a pharmacist or doctor about side effects.
6 brands · 5 makers in the NepalDoc catalog — see the full Orlistat guide →
Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F). Keep bottle tightly closed. ORLISTAT should not be used after the given expiration date.
Storage information from the U.S. FDA-approved label for Orlistat.
What is Slimage?
Slimage 120mg Tablet is a Orlistat medicine made by Deurali Janta Pharmaceuticals Pvt. Ltd. It comes as 120mg Tablet.
What is Slimage used for?
Orlistat is used for Obesity.
What is the generic name of Slimage?
The generic name of Slimage is Orlistat.
Which brands of Orlistat are available in Nepal?
6 brands of Orlistat are listed in the NepalDoc catalog, from 5 makers — including Obeslim 120mg Capsule, ORLES 120MG Capsule, Orlistat 120mg Tablet, Orlithin 120mg Capsule, Orlithin 60mg Capsule.
What are the side effects of Orlistat?
Most common treatment emergent adverse reactions (≥5% and at least twice that of placebo) include oily spotting, flatus with discharge, fecal urgency, fatty/oily stool, oily evacuation, increased defecation and fecal incontinence.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
